0PUD4KZ
Supplement Humeral Head, Left to No Qualifier with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach
Procedural Specifications
| Clinical Axis | Detail Definition |
|---|---|
| Section | 0 Medical and Surgical |
| Body System | P Upper Bones |
| Operation | U Supplement |
| Body Part | D Humeral Head, Left |
| Approach | 4 Percutaneous Endoscopic |
| Device | K Nonautologous Tissue Substitute |
| Qualifier | Z No Qualifier |
Operation Definition
Putting in or on biological or synthetic material that physically reinforces and/or augments the function of a portion of a body part
Procedure Overview
Supplement procedures add biological or synthetic material to reinforce or augment a bone of the skull, face, thorax, or upper limb that remains anatomically in place, rather than replacing or repairing damaged tissue. Common examples include bone grafting to reinforce a weakened area of the skull, or augmenting a thin area of the sternum or scapula with mesh or cement to add structural strength.
This approach is chosen when the native bone is largely intact and functional but needs extra support, often to prevent future fracture, to build up bone stock before another procedure, or to strengthen a surgical repair site.
Anatomy & Axis Detail
Humeral Head, Left
The left humeral head forms the ball of the shoulder joint and can develop focal bone loss from avascular necrosis, recurrent instability, or impaction injury, all of which compromise its smooth articulation with the glenoid. Supplement procedures here involve grafting bone or adding a structural material to rebuild the deficient portion of the head, restoring a rounded, congruent surface that allows normal joint motion and provides adequate support if a shoulder replacement is planned. Because even small defects in this area can alter how the joint tracks, the graft's shape and size are as important as the material chosen. Documentation should reflect left-sided laterality along with the graft type and the extent of the humeral head involved.
Approach: Percutaneous Endoscopic
Percutaneous Endoscopic combines a puncture through skin or mucous membrane with insertion of an endoscope to visualize the procedure internally, as in laparoscopic cholecystectomy. It is distinguished from plain Percutaneous by the presence of scope-guided visualization, and from Via Natural or Artificial Opening Endoscopic by its route being a new puncture rather than an existing orifice or stoma.
Device: Nonautologous Tissue Substitute
Nonautologous Tissue Substitute refers to biologic material sourced from a donor or another species, such as an allograft or xenograft, used to replace a body part. It differs from Autologous Tissue Substitute by tissue origin outside the patient's own body, and from Synthetic Substitute by being biologic rather than manufactured material.
Coding & Documentation
Coders should confirm the operative note describes material being added to reinforce a structure that stays in place, not material substituting for a removed part. The device or graft type documented determines the correct device value - autograft, allograft, synthetic substitute, or nonautologous tissue - so vague documentation of "bone graft" without a source can complicate accurate coding. A common mistake is coding supplement when the surgeon actually performed a replacement, particularly in cranioplasty cases where it's unclear whether native bone was removed first. Another frequent error is missing a supplement code entirely when a graft was placed during a repair or reposition procedure, since it may require a separate code rather than being bundled in.